The Role of Diagnostic Biomarkers, Omics Strategies, and Single-Cell Sequencing for Nonalcoholic Fatty Liver Disease in Severely Obese Patients

Liver disease due to metabolic dysfunction constitute a worldwide growing health issue. Severe obesity is a particularly strong risk factor for non-alcoholic fatty liver disease, which affects up to 93% of these patients. Current diagnostic markers focus on the detection of advanced fibrosis as the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wernberg, Charlotte W., Ravnskjaer, Kim, Lauridsen, Mette M., Thiele, Maja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957539/
https://www.ncbi.nlm.nih.gov/pubmed/33804302
http://dx.doi.org/10.3390/jcm10050930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957539/
https://www.ncbi.nlm.nih.gov/pubmed/33804302
http://dx.doi.org/10.3390/jcm10050930

Ejemplares similares